Does 4-factor prothrombin concentrate (4F-PCC) reduce 24 h blood product consumption in trauma patients at risk of massive transfusion?

CJEM. 2023 Dec;25(12):946-948. doi: 10.1007/s43678-023-00587-y. Epub 2023 Sep 26.

Authors

Hailey Newton¹, Doran Drew^{2

3}, Jeffrey J Perry^{2

4}

Affiliations

¹ Department of Emergency Medicine, The Ottawa Hospital, University of Ottawa, Ottawa, ON, Canada. hnewton@toh.ca.
² Department of Emergency Medicine, The Ottawa Hospital, University of Ottawa, Ottawa, ON, Canada.
³ Department of Surgery, Division of Trauma, University of Ottawa, Ottawa, ON, Canada.
⁴ Ottawa Hospital Research Institute, Ottawa, ON, Canada.

PMID: 37752388
DOI: 10.1007/s43678-023-00587-y

No abstract available

Publication types

Editorial

MeSH terms

Anticoagulants* / adverse effects
Blood Coagulation Factors / therapeutic use
Blood Transfusion
Humans
Prothrombin*
Retrospective Studies

Substances

Prothrombin
Anticoagulants
Blood Coagulation Factors